Dianthus Therapeutics
DNTH
DNTH
76 hedge funds and large institutions have $782M invested in Dianthus Therapeutics in 2024 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 24 increasing their positions, 8 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
95% more funds holding
Funds holding: 39 → 76 (+37)
19.41% more ownership
Funds ownership: 69.44% → 88.85% (+19%)
Holders
76
Holding in Top 10
6
Calls
–
Puts
–
Top Buyers
| 1 | +$89.8M | |
| 2 | +$70M | |
| 3 | +$58.3M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$45M |
| 5 |
VA
VR Adviser
New York
|
+$35M |
Top Sellers
| 1 | -$7.19M | |
| 2 | -$6.91M | |
| 3 | -$3.42M | |
| 4 |
AVLSA
Atlas Venture Life Science Advisors
Cambridge,
Massachusetts
|
-$1.5M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$415K |